Zelira Therapeutics Ltd Sustainability Reports
Zelira Therapeutics Limited is a biopharmaceutical company engaged in the research, development, and commercialization of clinically validated cannabinoid-based medicines. The company focuses on developing treatments for medical conditions such as insomnia, autism, and chronic non-cancer pain.
Sector: Manufacturing
Country: Australia
Exchange: Australian Securities Exchange
LEI: 529900KQT1MZNOEB4525
FIGI: BBG001SJGQT9
5 reports from 2020 to 2024